Scalper1 News
Here is why shares of biotech Gilead Sciences (GILD) and three four other highly rated stocks are rallying in heavy volume today. Gilead began running up in premarket trading after drug giant Merck (MRK) said Sunday it would not move forward with development of a drug combination aimed at shortening treatment time for hepatitis C, citing disappointing clinical data. The treatment would have used Gilead’s Sovaldi, but also would compete with the Scalper1 News
Scalper1 News